Joshua Garrett Cohen, Associate Professor, Medical Director O.C. Gynecologic Cancer Program, City of Hope Orange County, shared a post on X:
“Very impactful data in the genetics session this am SGOAM 2026, estrogen replacement is safe in premenopausal BRCA mutation carriers and they should be offered this after risk reducing surgery.
Dr. Blank highlighted the need to lead the charge in prevention and counseling.”
Other articles featuring Joshua G. Cohen on OncoDaily.
